Related references
Note: Only part of the references are listed.Serotonin in Parkinson's disease
Marios Polotis et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Selective Dysfunction of Basal Ganglia Subterritories: From Movement to Behavioral Disorders
Leon Tremblay et al.
MOVEMENT DISORDERS (2015)
Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease
S. Mazzucchi et al.
ACTA NEUROLOGICA SCANDINAVICA (2015)
Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients
Marios Politis et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Combined Fenobam and Amantadine Treatment Promotes Robust Antidyskinetic Effects in the 1-Methyl-4-Phenyl1,2,3,6-Tetrahydropyridine ( MPTP)-Lesioned Primate Model of Parkinson's Disease
Wai Kin D. Ko et al.
MOVEMENT DISORDERS (2014)
Neuroimaging in Parkinson disease: from research setting to clinical practice
Marios Politis
NATURE REVIEWS NEUROLOGY (2014)
Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats
Melissa M. Conti et al.
NEUROPHARMACOLOGY (2014)
Presynaptic mechanisms of L-DOPA-induced dyskinesia: the findings, the debate, and the therapeutic implications
M. Angela Cenci
FRONTIERS IN NEUROLOGY (2014)
Serotonin system implication in L-DOPA-induced dyskinesia: from animal models to clinical investigations
Manolo Carta et al.
FRONTIERS IN NEUROLOGY (2014)
A multi-atlas based method for automated anatomical Macaca fascicularis brain MRI segmentation and PET kinetic extraction
Benedicte Ballanger et al.
NEUROIMAGE (2013)
Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD
Clare Loane et al.
NEUROLOGY (2013)
SERT-to-DAT ratios in early Parkinson's disease do not correlate with the development of dyskinesias
Sven R. Suwijn et al.
EJNMMI RESEARCH (2013)
A critique of available scales and presentation of the non-human primate dyskinesia rating scale
Susan H. Fox et al.
MOVEMENT DISORDERS (2012)
Lewy pathology and neurodegeneration in premotor Parkinson's disease
Kelly Del Tredici et al.
MOVEMENT DISORDERS (2012)
Effects of dopamine and serotonin antagonist injections into the striatopallidal complex of asymptomatic MPTP-treated monkeys
Sara Neumane et al.
NEUROBIOLOGY OF DISEASE (2012)
Modeling Parkinson's Disease in Primates: The MPTP Model
Gregory Porras et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Therapies for Dopaminergic-Induced Dyskinesias in Parkinson Disease
Mildred D. Gottwald et al.
ANNALS OF NEUROLOGY (2011)
Characterization of 3,4-Methylenedioxymethamphetamine (MDMA) Enantiomers In Vitro and in the MPTP-Lesioned Primate: R-MDMA Reduces Severity of Dyskinesia, Whereas S-MDMA Extends Duration of ON-Time
Philippe Huot et al.
JOURNAL OF NEUROSCIENCE (2011)
Graft-Induced Dyskinesias in Parkinson's Disease: High Striatal Serotonin/Dopamine Transporter Ratio
Marios Politis et al.
MOVEMENT DISORDERS (2011)
Impact of dopamine to serotonin cell ratio in transplants on behavioral recovery and L-DOPA-induced dyskinesia
Joanna Garcia et al.
NEUROBIOLOGY OF DISEASE (2011)
The serotonergic system in Parkinson's disease
Philippe Huot et al.
PROGRESS IN NEUROBIOLOGY (2011)
Maladaptive Plasticity of Serotonin Axon Terminals in Levodopa-Induced Dyskinesia
Daniella Rylander et al.
ANNALS OF NEUROLOGY (2010)
Serotonin 2A Receptors and Visual Hallucinations in Parkinson Disease
Benedicte Ballanger et al.
ARCHIVES OF NEUROLOGY (2010)
Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation
Stephane Thobois et al.
BRAIN (2010)
Neuropsychiatric Behaviors in the MPTP Marmoset Model of Parkinson's Disease
Susan H. Fox et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2010)
Increased 5-HT2A Receptors in the Temporal Cortex of Parkinsonian Patients with Visual Hallucinations
Philippe Huot et al.
MOVEMENT DISORDERS (2010)
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
K. Ray Chaudhuri et al.
LANCET NEUROLOGY (2009)
Pathophysiology and treatment of psychosis in Parkinson's disease - A review
Laura B. Zahodne et al.
DRUGS & AGING (2008)
Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results
Christopher G. Goetz et al.
MOVEMENT DISORDERS (2008)
Parkinson's disease - opportunities for novel therapeutics to reduce the problems of levodopa therapy
Susan H. Fox et al.
SEROTONIN-DOPAMINE INTERACTION: EXPERIMENTAL EVIDENCE AND THERAPEUTIC RELEVANCE (2008)
A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery
Stephanie Mounayar et al.
BRAIN (2007)
MDMA and fenfluramine reduce L-DOPA-induced dyskinesia via indirect 5-HT1A receptor stimulation
Christopher Bishop et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Clinical characteristics in early Parkinson's disease in a Central California population-based study
GA Kang et al.
MOVEMENT DISORDERS (2005)
Defining the Parkinson's disease phenotype: initial symptoms and baseline characteristics in a clinical cohort
RJ Uitti et al.
PARKINSONISM & RELATED DISORDERS (2005)
(+/-)3,4-methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: Studies in animals
GA Ricaurte et al.
NEUROPSYCHOBIOLOGY (2000)
Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey
C Imbert et al.
JOURNAL OF NEUROSCIENCE METHODS (2000)
Share Paper
